Loading...
A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain
C-X-C chemokine receptor type 4 (CXCR4) is a receptor for a pleiotropic chemokine CXCL12. Previous studies have shown that the acute administration of the CXCR4 antagonist AMD3100 reduced neuroinflammation in stroke brain and mobilized bone marrow hematopoietic stem cells (HSCs). The purpose of this...
Na minha lista:
Udgivet i: | Cell Transplant |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
SAGE Publications
2017
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5661213/ https://ncbi.nlm.nih.gov/pubmed/27938478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096368916X693563 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|